Rubella
📧 Sign up to get email alerts when something new happens for Rubella.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR [Phase 4]
Phase 4 trial assessing whether the measles-mumps-rubella vaccine virus is excreted in breast milk after postpartum vaccination; the study s…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age [Phase 3]
This Phase 3 clinical trial evaluates the immune response and safety of an investigational combined measles, mumps, rubella and varicella va…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines
This clinical trial update examines five-year antibody persistence after vaccination with IPV, MMR, and HepA-L vaccines. The study is not ye…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months [Phase 3]
Phase 3 trial comparing SIBP's Measles-Mumps-Rubella vaccine with GlaxoSmithKline's MMR vaccine in children aged 9-11 months has completed.
-
EMA approval · 2025-10-30EMA Authorised: M-M-RVaxPro (measles virus Enders’ Edmonston strain (live, attenuated);mumps virus Jeryl Lynn (level B) strain (live, attenuated);rubella virus Wistar RA 27/3 strain (live, attenuated)) — Merck Sharp & Dohme B.V.
The EMA authorised Merck's M-M-RVaxPro, a live attenuated measles‑mumps‑rubella vaccine, for immunization against measles, mumps and rubella…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-09-25EMA Authorised: ProQuad (virus, live attenuated, measles, virus, live attenuated, mumps, virus, live attenuated, rubella, virus, live attenuated, varicella) — Merck Sharp & Dohme B.V.
EMA has authorized ProQuad, a live attenuated vaccine that protects against varicella (chickenpox), measles, mumps and rubella in the Europe…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) [Phase 4]
Phase 4 trial evaluating immunogenicity when a Japanese encephalitis vaccine is co-administered with a Measles-Mumps-Rubella vaccine; the st…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections
A prospective clinical registry evaluating exanthematous infections and coinfections, including dengue fever, chikungunya, measles, and rube…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age [Phase 4]
A Phase 4 CDC-sponsored study assessed the immunogenicity of the Measles-Rubella vaccine in infants at 6 and 9 months, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age [Phase 2]
Phase 2 trial comparing immune response and safety of a combined measles, mumps, rubella, and varicella vaccine against a marketed MMRV vacc…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Study of Concomitant Administration of the sIPV and DTaP or MMR [Phase 4]
Phase 4 trial evaluating concomitant administration of Sabin inactivated polio vaccine (sIPV) with DTaP or MMR vaccines; sponsored by the In…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine [Phase 4]
Phase 4 trial update evaluating a live attenuated varicella vaccine co-administered with MMR or DTaP vaccines; study status is NOT_YET_RECRU…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months [Phase 3]
A Phase 3 clinical trial is evaluating non-interference between the Measles-Rubella (MR) vaccine and the Yellow Fever vaccine in Bangladeshi…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of a pneumococcal conjugate vaccine when administered concomitantly with routine pediatri…
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of MMR Vaccination [NA]
This completed trial evaluated how varied outreach methods affect appointment scheduling, appointment completion, and receipt of the Measles…
-
CLINICAL_TRIALS trial_result · 2024-01-08Clinical Trial Update: Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination [Phase 3]
A Phase 3 clinical trial update evaluating immune responses in individuals fully vaccinated against measles, mumps, and rubella and response…
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines [Phase 4]
Phase 4 trial updating immunogenicity and safety of an inactivated SARS-CoV-2 vaccine when coadministered with two attenuated vaccines, focu…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial [Phase 1, Phase 2]
Phase 1/2 trial evaluating a microneedle patch for measles and rubella vaccination completed.
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine [Phase 4]
Phase 4 trial update examining immunogenicity and safety of HPV vaccine co-administered with MMR vaccine.
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: MMR at 6 Months Trial [Phase 4]
A Phase 4 clinical trial update for the measles-mumps-rubella vaccine completed its study.
-
CLINICAL_TRIALS trial_result · 2020-09-18Clinical Trial Update: Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine [Phase 4]
Phase 4 trial assessing immunogenicity and safety of the Japanese Encephalitis Vaccine when administered with the MMR vaccine.
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella [Phase 2, Phase 3]
A Phase 2/3 trial evaluated immunogenicity, reactogenicity, and safety of a double viral vaccine for measles and rubella. The study has comp…
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) [Phase 3]
Phase 3 study comparing frozen versus refrigerated MMRV vaccine (V221-016) completed.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children [Phase 4]
Phase 4 clinical trial update on reactogenicity and immunogenicity after measles-rubella routine immunization in Indonesian infants and chil…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Rubella Susceptibility in Multiparous Women
The clinical trial NCT00401505, sponsored by Unity Health Toronto, studying rubella susceptibility in multiparous women, has completed.